Jan-Olav Henck

Jan-Olav holds a doctoral degree from the Faculty of Natural Science, Leopold-Franzens University, Innsbruck and postdoc from the Department of Chemistry, Ben-Gurion University of the Negev, Israel. He has over two decades of experience across both small and large molecule pharmaceutical development, including API and drug product work from late lead optimization to commercialization. He is also experienced in drug formulation production under cGMP conditions. His prior experience includes working with SSIC Inc and Aptuit LLC. Prior to joining Syngene, he was the Vice President and Head of Formulations Development at Bayer AG. He has over twelve research publications and several patents to his credit. As a member of the Executive Committee, he oversees the development value chain connecting upstream discovery service programs that transition into downstream development programs and support smooth transition into commercial manufacturing.